Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Collagen Solutions	Hemogenyx Pharmaceuticals	Pascal Biosciences	Synthetic Biologics	Living Cell Technologies
Symbol	LON:COS	LON:HEMO	CVE:PAS	NYSEAMERICAN:SYN	ASX:LCT
Price Information
Current Price	GBX 3.20	GBX 7.02	C$0.11	$0.39	A$0.01
52 Week Range	N/A	N/A	N/A	Buy	N/A
Beat the Market™ Rank
Overall Score	0.7	0.4	0.6	1.2	0.6
Analysis Score	0.0	0.0	0.0	3.5	0.0
Community Score	2.9	2.0	2.8	2.7	2.8
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	0.0	0.0	0.0	0.0
Earnings & Valuation Score	0.6	0.0	0.0	0.0	0.0
Analyst Ratings
Consensus Recommendation	N/A	N/A	N/A	Buy	N/A
Consensus Price Target	N/A	N/A	N/A	$1.25	N/A
% Upside from Price Target	N/A	N/A	N/A	219.86% upside	N/A
Trade Information
Market Cap	£14.42 million	£26.97 million	C$7.34 million	$5.54 million	$7.43 million
Beta	N/A	N/A	N/A	N/A	N/A
Average Volume	293,832	8,010,000	81,894	314,673	N/A
Sales & Book Value
Annual Revenue	£4.43 million	N/A	N/A	N/A	$708,094.00
Price / Sales	3.20	N/A	N/A	N/A	10.49
Cashflow	GBX 1.28 per share	GBX 0.10 per share	C$0.01 per share	N/A	A$0.01 per share
Price / Cash	2.50	71.00	19.17	N/A	2.17
Book Value	GBX 5.10 per share	GBX (0.10) per share	C$0.00 per share	N/A	A$0.01 per share
Price / Book	0.01	N/A	N/A	N/A	1.86
Profitability
Net Income	N/A	N/A	N/A	N/A	N/A
EPS	GBX (0.40)	GBX (0.40)	C($0.05)	N/A	A$0.00
Trailing P/E Ratio	N/A	N/A	N/A	0.00	N/A
Forward P/E Ratio	∞	∞	∞	∞	∞
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	N/A	N/A	N/A	N/A
Return on Equity (ROE)	N/A	N/A	N/A	N/A	N/A
Return on Assets (ROA)	N/A	N/A	N/A	N/A	N/A
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	9.51%	415.66%	N/A	N/A	6.99%
Current Ratio	2.32%	3.05%	0.37%	N/A	9.82%
Quick Ratio	2.16%	2.92%	0.14%	N/A	9.73%
Ownership Information
Institutional Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Insider Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Miscellaneous
Employees	48	N/A	4	13	N/A
Shares Outstanding	443.68 million	397.25 million	56.44 million	18.26 million	571.44 million
Next Earnings Date	N/A	N/A	N/A	8/13/2020 (Estimated)	N/A
Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources